CERS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CERS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cerus's enterprise value is $339.9 Mil. Cerus's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was $-9.2 Mil. Therefore, Cerus's EV-to-EBITDA for today is -37.05.
The historical rank and industry rank for Cerus's EV-to-EBITDA or its related term are showing as below:
During the past 13 years, the highest EV-to-EBITDA of Cerus was -3.20. The lowest was -39.91. And the median was -12.98.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-12-14), Cerus's stock price is $1.71. Cerus's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.110. Therefore, Cerus's PE Ratio (TTM) for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
The historical data trend for Cerus's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cerus Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
EV-to-EBITDA | Get a 7-Day Free Trial | -9.40 | -20.81 | -24.83 | -18.92 | -16.04 |
Cerus Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
EV-to-EBITDA | Get a 7-Day Free Trial | -7.97 | -16.04 | -19.14 | -28.61 | -37.73 |
For the Medical Devices subindustry, Cerus's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Cerus's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Cerus's EV-to-EBITDA falls into.
Cerus's EV-to-EBITDA for today is calculated as:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA (TTM) |
= | 339.906 | / | -9.174 | |
= | -37.05 |
Cerus's current Enterprise Value is $339.9 Mil.
Cerus's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cerus (NAS:CERS) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cerus's PE Ratio (TTM) for today is calculated as:
PE Ratio (TTM) | = | Share Price (Today) | / | Earnings per Share (Diluted) (TTM) |
= | 1.71 | / | -0.110 | |
= | At Loss |
Cerus's share price for today is $1.71.
Cerus's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.110.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Please read Which price ratio outperforms the enterprise multiple?
Thank you for viewing the detailed overview of Cerus's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Kevin Dennis Green | officer: Chief Accounting Officer | C/O CERUS CORPORATION, 2411 STANWELL DRIVE, CONCORD CA 94520 |
Chrystal Menard | officer: Chief Legal Officer | C/O CERUS CORPORATION, 2550 STANWELL DRIVE, CONCORD CA 94520 |
Richard J Benjamin | officer: Chief Medical Officer | 15 WHITE PINE ROAD, NEWTON MA 02464 |
Hua Shan | director | C/O CERUS CORPORATION, 1220 CONCORD AVE., STE. 600, CONCORD CA 94520 |
Jami K Nachtsheim | director | |
Swisher Daniel N Jr | director | C/O SUNESIS PHARMACEUTICALS, INC., 395 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO CA 94080 |
Frank Witney | director | 940 WINTER STREET, C/O PERKINELMER, WALTHAM MA 02451 |
William Mariner Greenman | officer: President, Cerus Europe | C/O CERUS CORPORATION, 2411 STANWELL DRIVE, CONCORD CA 94520 |
Laurence M Corash | director | C/O CERUS CORP, 2411 STENWELL DRIVE, CONCORD CA 94520 |
Vivek K Jayaraman | officer: Chief Commercial Officer | 3910 BRICKWAY BLVD, SANTA ROSA CA 95403 |
Carol Moore | officer: SR. V.P. Regulatory, Clinical | C/O CERUS CORPORATION, 2550 STANWELL DRIVE, CONCORD CA 94520 |
Eric Bjerkholt | director | 132 PURDURE AVENUE, KENGSINGTON CA 94708 |
Ann Lucena | director | C/O CERUS CORPORATION, 1220 CONCORD AVE. SUITE 600, CONCORD CA 94520 |
Gail Schulze | director | 3451 WELLS ROAD, MALVERN PA 19355 |
Timothy B Anderson | director | C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015 |
From GuruFocus
By GuruFocus Research • 09-06-2024
By Business Wire • 07-02-2024
By Business Wire • 10-16-2024
By GuruFocus News • 10-09-2024
By Business Wire • 10-18-2024
By Business Wire • 11-13-2024
By Business Wire • 03-19-2024
By Business Wire • 07-18-2024
By Business Wire • 06-21-2024
By GuruFocus Research • 08-01-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.